CBIO vs ZVRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CBIO

46.8
AI Score
VS
CBIO Wins

ZVRA

44.8
AI Score

Investment Advisor Scores

CBIO

47score
Recommendation
HOLD

ZVRA

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO ZVRA Winner
Net Income -48.12M -2.93M ZVRA
Operating Income -51.09M -6.97M ZVRA
ROE -29.5% 25.6% ZVRA
ROA -26.3% -2.6% ZVRA
Total Assets 182.76M 111.94M CBIO
Cash 171.59M 77.33M CBIO
Current Ratio 9.66 19.06 ZVRA

Relative Price Performance (Last 90 Days)

CBIO 1M: +0.7% · 3M: -15.2% ZVRA 1M: -5.2% · 3M: +13.2%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

ZVRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $11.87

Fundamentals Snapshot

Metric CBIO ZVRA
Market Cap
Forward P/E -6.5 11.6
Trailing P/E 12.4
Revenue (TTM)
Revenue Growth 0.0% 0.5%
Gross Margin 1.0% 1.0%
Operating Margin -14.3% 0.4%
EPS -0.13 0.93
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.